NCT05428345View on ClinicalTrials.gov

A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Ulcerative ColitisCrohn's DiseaseInflammatory Bowel Disease (IBD)
Trial Locations (1)

10326

RECRUITING

Donggguk University Ilsan Hospital, Goyang-si

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY